Background
==========

Multiple Endocrine Neoplasia type 1 (MEN1, OMIM 131100) is an autosomal dominant disorder characterized by endocrine tumors of parathyroid, pancreatic islets and pituitary \[[@B1]\]. The prevalence of MEN1 is estimated to be 2--10 per 100,000 \[[@B2]\]. Based on loss of heterozygosity in tumors and Knudson\'s \"two-hit\" hypothesis, the *MEN1*gene was classified as a tumor suppressor \[[@B2],[@B3]\] and the gene was isolated in 1997 by positional cloning \[[@B4]\]. The *MEN1*gene spans 9 kb of the genome, is comprised of 10 exons, and codes for a 610 amino acid protein termed menin \[[@B4]\]. More than 300 independent germline and somatic mutations have been identified \[[@B5]\]. Recently, five new germline mutations which affect splicing of pre-mRNA transcribed from *MEN1*gene were identified in our laboratory \[[@B6]\]. The nature of all the disease-inducing mutations points to a loss of function of menin, which is characteristic of a tumor suppressor. Database analysis of menin protein sequence reveals no significant homology to known consensus protein motifs. Menin is widely expressed in both endocrine and non-endocrine tissues \[[@B4]\]. Menin is primarily localized in the nucleus and contains two nuclear localization signal sequences near the carboxyl terminus of the protein \[[@B7]\].

Studies on the function of menin have not yielded a clear picture as to the role of menin as a tumor suppressor; however, the results of these studies suggest some interesting possibilities. Two groups \[[@B8],[@B9]\], based on yeast two-hybrid screening of a human adult brain library, reported that menin interacts with JunD (a member of the AP-1 transcription factor family) and represses JunD mediated transcription. Recently, Agarawal *et al*\[[@B10]\] reported that when JunD loses its association with menin it becomes a growth promoter rather than a growth suppressor. Other reports suggest some relevance of the menin-JunD interaction. JunD null male mice exhibit impaired spermatogenesis \[[@B11]\]. In postnatal mouse, *Men1*was found to be expressed in testis (spermatogonia) at high levels \[[@B12]\]. Lemmens *et al*\[[@B13]\] by screening a 12.5 dpc mouse embryo library with menin, identified a homeobox-containing mouse protein, Pem. Interestingly, both menin and Pem showed a very similar pattern of expression, especially in testis and Sertoli cells. These findings along with the fact that some MEN1 patients have idiopathic oligospermia and non-motility of spermatozoa \[[@B14]\] suggest that menin-JunD and menin-PEM interactions may play a vital role in spermatogenesis. Kaji *et al*\[[@B15]\] observed that menin interacts with Smad3 and inactivation of the former blocks transforming growth factor beta (TGF-β) signaling in pituitary tumor derived cell lines. Recently, two more menin interacting proteins, NF-kappa B \[[@B16]\] and a putative tumor metastasis suppressor nm23 \[[@B17]\] have been identified. Interactions among AP-1 family members, Smad proteins and NF-kappa B have been documented \[[@B18]-[@B21]\] and such cross talk among signaling pathways is not uncommon.

Despite the above studies, a clear consensus of the molecular mechanisms leading to neoplasia, following the loss of menin, has not emerged. Very little is known about the gene expression changes in human neuroendocrine tumors following the loss of menin. Global gene expression analyses, using cDNA microarrays, have been used to classify other human tumors into clinically distinct categories \[[@B22]-[@B26]\]. Wu \[[@B27]\] has discussed the mathematical and statistical considerations for the use of DNA microarrays to identify genes of specific interest, and Harkin \[[@B28]\] has used expression profiling to identify downstream transcriptional targets of the BRCA1 tumor suppressor gene. Our objective was to identify genes that might be directly or indirectly over or under-expressed as a consequence of loss of menin expression.

Results
=======

Patients and Controls
---------------------

Eight neuroendocrine tumors from six MEN1 patients were included in this study. The patient ages were 19, 22, 42, 51, 57, and 57 years at the time of surgery (Table [1](#T1){ref-type="table"}). One was female, and five were male. Two of the patients had clinical and laboratory findings consistent with insulinoma. Three tumors were analyzed from one of these patients. One patient had findings consistent with VIP-oma (vasoactive intestinal polypeptide secreting tumor). Two patients, with no specific symptoms, had non-functioning or pancreatic polypeptide secreting tumors. One patient had symptoms of gastrinoma from a duodenal tumor (not used for this analysis). A pancreatic tumor from this patient, found incidentally, was used in this study. Pathological examination of tumors from the 6 patients resulted in the classification of 3 insulinomas, 3 neuroendocrine tumors, 1 VIP-oma and 1 glucagonoma. The ages of the individuals donating normal pancreatic islets were 42, 52(2), and 56 years. Two were female, and two were male.

###### 

Characteristics of patients and normal subjects.

  **Pt.\#**   **T \#**   **Age**   **Sex**   **Clinical**           **LN Mets**   **T Vol. (ml)**   **Menin Defect \[6\]**
  ----------- ---------- --------- --------- ---------------------- ------------- ----------------- ----------------------------
  1           1          19        F         Insulinoma             0/1           8.28              Large Deletion, exon 1 & 2
  2           2          42        M         Neuroendocrine Tumor   0/14          18.75             Nonesense Mutation, exon 7
  6           6          60        M         VIP-oma                1/16          288               8 bp Deletion, exon 5
  7           7          51        M         Neuroendocrine Tumor   2/30          3.75              2 bp Deletion, exon 2
  8           8--10      22        M         Insulinoma             2/8           6.9               2 bp Deletion, exon 2
  11          11         57        M         Gastrinoma             1/1           0.5               4 bp Deletion, exon 3
  N1          N1         52        M         Normal                 NA            NA                NA
  N2          N2         56        F         Normal                 NA            NA                NA
  N3          N3         52        F         Normal                 NA            NA                NA
  N4          N4         42        M         Normal                 NA            NA                NA

Quality of Hybridization
------------------------

The RNA isolated from 8 tumor specimens (6 patients) and 4 normal islet preparations was of acceptable quality for hybridization, as determined by preliminary small hybridizations on test chips. The dChip computer program returned data concerning the percent of genes judged to be present, and the percent of single and array outlier events (Table [2](#T2){ref-type="table"}). The expression data from one normal islet preparation had 5.94% array outliers, which prompted dChip to issue a warning (a warning indicates more than 5% array outliers detected). However, since we had only four normal specimens, we elected to include all four in our analysis. The average level of gene expression was computed for each gene (Figure [1](#F1){ref-type="fig"}). The average gene expression level for all genes followed an exponentially decreasing pattern; the greatest number of genes had expression values less than 100, and only a few genes had expression levels greater than 4000.

###### 

Overall statistics on the quality of each the processed GeneChips. One chip was used for each tumor/normal specimen. The \"Median Intensity\" refers to the overall brightness of the fluorescence of the genes. The \"Present Call\" refers to whether the gene was \"present\" or \"absent\".

  **Chip Name**   **Median Intensity**   **Present Call (%)**   **Array outlier %**   **Single outlier %**   **Warning**
  --------------- ---------------------- ---------------------- --------------------- ---------------------- -------------
  T1              170                    49.4                   1.12                  0.11                   
  T2              107                    46.2                   1.54                  0.15                   
  T6              160                    51.4                   1.16                  0.12                   
  T7              132                    47.7                   0.50                  0.08                   
  T8              158                    51.0                   0.59                  0.10                   
  T9              114                    48.9                   0.66                  0.10                   
  T10             158                    50.6                   0.42                  0.07                   
  T11             121                    46.1                   3.34                  0.30                   
  N1              142                    48.4                   2.65                  0.26                   
  N2              179                    49.7                   2.72                  0.24                   
  N3              75                     48.3                   3.38                  0.31                   
  N4              73                     33.2                   9.50                  0.63                   \*

![Histogram showing the frequency of genes being expressed at levels between 50 and 7875 (arbitrary expression units).](1476-4598-4-9-1){#F1}

Overall Consistency of Gene Expression
--------------------------------------

Average expression and standard deviation was computed for each gene in both the group of 4 normal islets, and the group of 8 islet tumors and expressed as the coefficient of variation (CV). Genes with average expression levels less than 50 were excluded from this analysis. Figure [2](#F2){ref-type="fig"} shows that the average (11,416 genes and expressed sequences) CV in the group of 8 tumors was 30%. There was a linear regression of CV values as the average minimum expression level of the genes increased. Genes with an average minimum expression level of 7000 or more had an average CV level of 12.7%. The analysis of genes expressed in the normal islets gave similar results. However, when the tumors were combined with the normals, the CV was higher than either group alone. This was caused by the true differences in gene expression levels between the tumors and the normals.

![Coefficient of variation (CV) of genes being expressed at levels between 50 and 6000. For each gene expressed at an average level of 50 or above, the CV was computed for the group of 8 tumors, for the group of 4 normals, and for the group of all 12 tumors and normals. As the lower limit of expression was increased, the number of genes represented in the CV decreased: there were 12,000 genes with expression levels of 50 or more, but only a few genes with expression levels of 6,500 or more.](1476-4598-4-9-2){#F2}

Clustering
----------

The experimental groups were clustered (figure [3](#F3){ref-type="fig"}) using a hierarchical clustering procedure \[[@B29],[@B30]\]. This cluster was based on the inclusion of all genes which had 33% to 67% of \"present\" calls made by the GeneChip software. The assignment of tumor type was made on the basis of principal hormone messenger RNA levels that were consistent with the clinical and biochemical findings (Table [3](#T3){ref-type="table"}). The principal bifurcation in the clustering occurred between the group that included the normal specimens and the three tumors with a predominance of insulin expression, on one hand, and the other tumor types on the other. The four normal islet preparations clustered together, separate from the tumors. Among the normal islets, the females clustered separately from the males. Among the tumors, all 3 insulinomas clustered together, separate from the VIP-oma, the glucagonoma and the PP-omas (pancreatic polypeptide producing tumors). It is also interesting that all the specimens clustered in a pattern of increasing malignancy going from normal at the bottom of the cluster to most malignant at the top.

###### 

Gene expression levels of islet hormone mRNAs in tumors and normals. VIP: Vasoactive intestinal polypeptide; PP: Pancreatic polypeptide.

                    **T1**   **T2**   **T6**   **T7**   **T8**   **T9**   **T10**   **T11**   **N1**   **N2**   **N3**   **N4**
  ----------------- -------- -------- -------- -------- -------- -------- --------- --------- -------- -------- -------- --------
  **pre-Gastrin**   864      530      678      392      600      383      209       395       1036     775      28       1192
  **Insulin**       9990     13       179      401      10195    240      8971      1831      10010    9752     9580     8158
  **Glucagon**      10       6482     2783     1198     10       8370     10        10        9037     8425     9043     7800
  **VIP**           351      278      10243    374      334      276      362       202       806      436      334      389
  **PP**            246      7257     577      5845     70       1805     211       8895      1897     7605     3598     1177

![Clustering of tumors and normals according to overall gene expression patterns. The predominant type of hormone expression (Table 3) is noted for each tumor/normal specimen.](1476-4598-4-9-3){#F3}

The genes were also clustered by the dChip software. A group of apoptosis-related genes was identified whose expression was significantly correlated with the Tumor/Normal assignment of the data. Twenty-four apoptosis-related genes represented by 26 different Affymetrix probes were identified in the overall hierarchical clustering. Nineteen of these genes were more highly expressed in the normal islets than in the islet tumors (Figure [4](#F4){ref-type="fig"}). Eighteen of the nineteen under expressed genes in the set of tumors had t-test p values (tumor vs. normal) \<= 0.037. All five of the apoptosis-related genes, that were more highly expressed in the tumors, had t-test p values \>0.05

![Clustering of apoptosis-related genes in tumors (T) and normals (N). Pink indicates strong, white indicates moderate, and blue indicates weak expression.](1476-4598-4-9-4){#F4}

Evaluation of Student\'s t-test
-------------------------------

Since the Student\'s t-test was designed to compare only one parameter in two populations, the simultaneous measurement of multiple genes might lead to an excessive number of false positives. In order to empirically determine the potential false positive rate, we started with 923 genes which had a p value \<=.05 and repeatedly scrambled the individual tests into groups 4 and 8 and then performed new t-tests. The average number of genes having a p value = \< .05 in 20 such scrambles was 51 (5.5% of 923 genes). This was only slightly more than the 46 genes expected (0.05 × 923). We therefore concluded that there was little chance of excess false positives in repeatedly using the Student\'s t-test.

Hormone Expression Profiles
---------------------------

In order to obtain a better picture of the nature of the tumors and normal islets in this study, the expression levels of the principal hormone RNA of pancreatic islets was examined (Table [3](#T3){ref-type="table"}). Tumors 1, 8, and 10 had high levels of insulin expression and came from patients with the clinical diagnosis of insulinoma. Tumor 6 had high levels of VIP and came from a patient with the clinical syndrome of VIP-oma. Tumors 2 and 7 had high levels of pancreatic polypeptide, and came from patients with only a diagnosis of neuroendocrine tumor. Tumor 9, which came from a patient with a clinical diagnosis of insulinoma had a high level of glucagon expression; the clinical diagnosis was apparently due to the other tumor (\#8) which did have a high level of insulin expression. One other apparent discrepancy between the clinical diagnosis and hormone expression profile occurred with tumor 11, which had high a level of glucagon expression. This patient had an additional duodenal tumor that was responsible for the gastrin secretion and the clinical diagnosis. All the normal islet preparations had high levels of insulin and glucagon expression, as expected.

Comparison of tumor and normal gene expression
----------------------------------------------

The reporting of differentially expressed genes was restricted to those in which the absolute ratio of Tumor to Normal was greater than or equal to 2, and which had a Student\'s t-test p value of less than or equal to .005. There were 193 genes that met the criteria. Expressed sequences with no known protein product were not included. There were 45 genes that were increased in the tumors relative to the normals, and 148 genes that were decreased. The fold-change in expression values ranged from +179 to -449. Genes were assigned to functional categories based on the Gene Ontology Consortium assignments <http://www.geneontology.org/>. There were 16 genes related to cell growth, 13 genes related to signal transduction, and 16 genes related to other functions which were increased in the group of tumors relative to the group of normal islets (Table [4](#T4){ref-type="table"}). There were 44 genes related to cell growth, 10 related to cell death, 10 related to embryogenesis, 5 related to nucleic acid binding, 21 related to cell signaling, and 58 related to other functions in the group of genes which were decreased in the islet tumors relative to the controls (Tables [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}, [8](#T8){ref-type="table"}).

###### 

Genes significantly increased in tumors.

  **GeneBank Accession**   **Gene**                                                   **Symbol**   **Normal Mean**   **Tumor Mean**   **Fold Change**   **P value**
  ------------------------ ---------------------------------------------------------- ------------ ----------------- ---------------- ----------------- -------------
                           **Cell Growth/Cycle**                                                                                                        
  X16323                   hepatocyte growth factor                                   HGF          11                116              10.77             0.003305
  AB017642                 oxidative-stress responsive 1                              OSR1         58                428              7.41              0.000819
  AL078641                 phorbolin-like protein                                     APOBEC3G     15                92               6.21              0.000158
  L17128                   gamma-glutamyl carboxylase                                 GGCX         64                346              5.37              0.000018
  D21089                   xeroderma pigmentosum, complementation group C             XPC          292               1278             4.38              0.000284
  AL050223                 vesicle-associated membrane protein 2                      VAMP2        360               1533             4.26              0.002196
  D38145                   prostaglandin I2 synthase                                  PTGIS        29                121              4.09              0.000448
  AF092563                 structural maintenance of chromosomes 2-like 1             SMC2L1       58                185              3.21              0.002352
  AF006087                 actin related protein 2/3 complex, subunit 4               ARPC4        292               865              2.96              0.000565
  AC004537                 inhibitor of growth family, member 3                       ING3         46                114              2.47              0.003976
  AF013168                 tuberous sclerosis 1                                       TSC1         35                86               2.45              0.001232
  AJ236876                 ADP-ribosyltransferase polymerase)-like 2                  ADPRTL2      32                76               2.34              0.003874
                           **Cell Death/Apoptosis**                                                                                                     
  D38435                   postmeiotic segregation increased 2-like                   PMS2L1       74                193              2.6               0.002976
  M61906                   phosphoinositide-3-kinase, regulatory subunit              PIK3R1       43                104              2.4               0.004387
                           **Signal Transduction**                                                                                                      
  U26710                   Cas-Br-M ectropic retroviral transforming sequence b       CBLB         21                177              8.4               0.000082
  AB010414                 guanine nucleotide binding protein, gamma 7                GNG7         59                334              5.68              0.003835
  U59913                   mothers against decapentaplegic homolog 5                  MADH5        14                73               5.22              0.004731
  AB004922                 Homo sapiens gene for Smad 3                               MADH3        93                443              4.76              0.001024
  L11672                   zinc finger protein 91                                     ZNF91        428               2007             4.69              0.000376
  D14838                   fibroblast growth factor 9                                 FGF9         27                108              3.97              0.000752
  W27899                   member RAS oncogene family                                 RAB6B        68                232              3.43              0.00501
  U48251                   protein kinase C binding protein 1                         PRKCBP1      40                127              3.18              0.001999
  U90268                   cerebral cavernous malformations 1                         CCM1         53                151              2.87              0.004392
  AL050275                 cysteine rich with EGF-like domains                        CRELD1       195               543              2.79              0.000828
  AB014600                 SIN3 homolog B, transcriptional regulator                  SIN3B        177               425              2.39              0.001924
  M27691                   cAMP responsive element binding protein 1                  CREB1        107               229              2.15              0.003559
  U85245                   phosphatidylinositol-4-phosphate 5-kinase, type II, beta   PIP5K2B      244               518              2.12              0.000441
  W25793                   ring finger protein 3                                      RNF3         163               326              2                 0.004947
                           **Nucleic Acid Binding**                                                                                                     
  D50912                   RNA binding motif protein 10                               RBM10        96                443              4.6               0.001925
  U41315                   makorin, ring finger protein, 4                            MKRN4        404               808              2                 0.000262
                           **Ligand Binding**                                                                                                           
  X67155                   kinesin-like 5                                             KIF23        64                368              5.76              0.001584
  AB028985                 ATP-binding cassette, sub-family A, member 2               ABC1         65                262              4.04              0.001234
  Z48482                   matrix metalloproteinase 15                                MMP15        139               495              3.56              0.003946
                           **Enzyme**                                                                                                                   
  X13794                   lactate dehydrogenase B                                    LDHB         396               1606             4.05              0.000845
  X15334                   creatine kinase, brain                                     CKB          939               2083             2.22              0.002008
  X60708                   dipeptidylpeptidase IV                                     DPP4         133               291              2.19              0.000697
  AC004381                 SA homolog                                                 SAH          283               599              2.11              0.000168
  AF000416                 exostoses-like 2                                           EXTL2        134               271              2.02              0.001314
                           **Embryogenesis**                                                                                                            
  U48437                   amyloid beta precursor-like protein 1                      APLP1        851               2433             2.86              0.001043
  U66406                   ephrin-B3                                                  EFNB3        168               438              2.6               0.00309
  D50840                   UDP-glucose ceramide glucosyltransferase                   UGCG         85                211              2.5               0.002554
                           **Other/Unknown**                                                                                                            
  L48215                   hemoglobin, beta                                           HBB          12                2099             178.78            0.001299
  J00153                   hemoglobin, alpha 1                                        HBA1         15                1249             82.25             0.001889
  U30521                   P311 protein                                               C5orf13      157               453              2.88              0.001431
  AB011169                 similar to S. cerevisiae SSM4                              TEB4         140               300              2.15              0.00154
  AL031432                 GCIP-interacting protein                                   P29          99                198              2                 0.002036

###### 

Genes significantly decreased in tumors.

  **GeneBank Accession**   **Gene Description**                                  **Symbol**   **Normal Mean**   **Tumor Mean**   **Fold Change**   **P value**
  ------------------------ ----------------------------------------------------- ------------ ----------------- ---------------- ----------------- -------------
                           **Cell Growth/Division**                                                                                                
  D17291                   regenerating protein I beta                           REG1B        6286              13               -499.46           0.000095
  X67318                   carboxypeptidase A1                                   CPA1         3928              121              -32.57            0.003205
  AI763065                 regenerating islet-derived 1 alpha                    REG1A        5641              334              -16.88            0.000001
  D29990                   solute carrier family 7, member 2                     SLC7A2       2988              445              -6.72             0.002204
  AB017430                 kinesin-like 4                                        KIFF22       1223              316              -3.87             0.000177
  Z25884                   chloride channel 1                                    CLCN1        2511              655              -3.84             0.00013
  X81438                   amphiphysin                                           AMPH         2686              752              -3.57             0.000002
  L03785                   myosin, light polypeptide 5                           MYL5         207               59               -3.51             0.000233
  W28062                   guanine nucleotide-exch. Prot. 2                      ARFGEF2      66                19               -3.46             0.003602
  X52486                   uracil-DNA glycosylase 2                              UNG2         2555              756              -3.38             0.000514
  M81933                   cell division cycle 25A                               CDC25A       312               96               -3.25             0.000005
  M69136                   chymase 1                                             CMA1         360               115              -3.13             0.004413
  U90543                   butyrophilin                                          BTN2A1       685               226              -3.04             0.000023
  X69086                   utrophin                                              UTRN         1325              457              -2.90             0.000011
  AF039241                 histone deacetylase 5                                 HDAC5        1124              393              -2.86             0.000319
  U49392                   allograft inflammatory factor 1                       AIF1         165               58               -2.82             0.000105
  U81992                   pleiomorphic adenoma gene-like 1                      PLAGL1       330               118              -2.80             0.004717
  L26336                   heat shock 70kD protein 2                             HSPA2        90                32               -2.79             0.000689
  F27891                   cytochrome c oxidase subunit VIa                      COX6A2       872               313              -2.79             0.000342
  D87673                   heat shock transcription factor 4                     HSF4         1964              721              -2.73             0.000453
  X97795                   RAD54-like                                            RAD54L       392               144              -2.72             0.001345
  X92689                   UDP-N-acetyl-alpha-D-galactosamine                    GALNT3       80                32               -2.50             0.000243
  Y08683                   carnitine palmitoyltransferase I                      CPT1B        1038              420              -2.47             0.000573
  U40622                   X-ray repair complementing defective repair 4         XRCC4        177               72               -2.45             0.000678
  U64315                   excision repair, complementation group 4              ERCC4        2122              868              -2.44             0.000045
  AB020337                 beta 1,3-galactosyltransferase                        B3GALT5      1489              635              -2.34             0.002613
  U40152                   origin recognition complex                            ORC1L        3671              1702             -2.16             0.001425
  M10943                   metallothionein 1F                                    MT1F         5691              2653             -2.14             0.001707
  X79882                   major vault protein                                   MVP          758               376              -2.02             0.001719
  AF035960                 transglutaminase 5                                    TGM5         3097              1542             -2.01             0.002951
                                                                                                                                                   
                           **Cell Death/Apoptosis**                                                                                                
  S81914                   immediate early response 3                            IER3         2209              480              -4.60             0.000307
  D80007                   programmed cell death 11                              PDCD11       457               129              -3.55             0.002358
  AF013956                 chromobox homolog 4                                   CBX4         1599              492              -3.25             0.00034
  U33284                   protein tyrosine kinase 2 beta                        PTK2B        693               237              -2.93             0.000763
  U90919                   likely partner of ARF1                                APA1         2687              1021             -2.63             0.000015
  X57110                   Cas-Br-M retroviral transforming                      CBL          1889              784              -2.41             0.000033
  AL050161                 pro-oncosis receptor                                  PORIMIN      1178              497              -2.37             0.00031
  U40380                   presenilin 1                                          PSEN1        1301              569              -2.29             0.00012
  D83699                   harakiri, BCL2 interacting protein                    HRK          768               338              -2.27             0.001321
  U07563                   v-abl viral oncogene homolog 1                        ABL1         1415              631              -2.24             0.000248
  M95712                   v-raf oncogene homolog B1                             BRAF         338               157              -2.16             0.004207
  M16441                   lymphotoxin alpha                                     LTA          2106              985              -2.14             0.000239
  AF035444                 pleckstrin homology-like domain, family A, member 2   PHLDA2       334               166              -2.01             0.001759

###### 

Genes significantly decreased in tumors (continued).

  **GeneBank Accession**   **Gene Description**                              **Symbol**   **Normal Mean**   **Tumor Mean**   **Fold Change**   **P value**
  ------------------------ ------------------------------------------------- ------------ ----------------- ---------------- ----------------- -------------
                           **Signal Transduction**                                                                                             
  J00306                   somatostatin                                      SST          7701              284              -27.09            0
  AI636761                 somatostatin                                      SST          7224              598              -12.09            0.000001
  AB011143                 GRB2-associated binding protein 2                 GAB2         2237              402              -5.57             0.001816
  M93056                   serine (or cysteine) proteinase inhibitor         SERPINB1     505               105              -4.80             0.004637
  X68830                   islet amyloid polypeptide                         IAPP         2231              477              -4.68             0.001221
  AB029014                 RAB6 interacting protein 1                        RAB6IP1      824               181              -4.56             0.000155
  AI198311                 neuropeptide Y                                    NPY          610               154              -3.96             0.004817
  M28210                   member RAS oncogene family                        RAB3A        2566              672              -3.82             0.000048
  J04040                   glucagon                                          GCG          8620              2351             -3.67             0.000396
  AF030335                 purinergic receptor P2Y                           P2RY11       2314              680              -3.40             0.000058
  M29335                   major histocompatibility complex                  HLA-DOA      906               268              -3.39             0.00159
  L38517                   Indian hedgehog homolog                           IHH          3013              897              -3.36             0.000055
  U95367                   gamma-aminobutyric acid A receptor, pi            GABRP        668               202              -3.30             0.000837
  W28558                   pleiotropic regulator 1                           PLRG1        704               216              -3.26             0.000068
  L08485                   gamma-aminobutyric acid A receptor, alpha 5       GABRA5       342               107              -3.20             0.000336
  AF004231                 leukocyte immunoglobulin-like receptor            LILRB2       93                30               -3.08             0.001105
  AF055033                 insulin-like growth factor binding protein 5      IGFBP5       126               43               -2.96             0.000257
  AJ010119                 ribosomal protein S6 kinase                       RPS6KA4      1532              522              -2.94             0.000201
  U46194                   Human renal cell carcinoma antigen                RAGE         2057              754              -2.73             0.000324
  L13858                   son of sevenless homolog 2                        SOS2         964               354              -2.72             0.000268
  Z29572                   tumor necrosis factor receptor superfamily        TNFRSF17     184               68               -2.69             0.000178
  U01134                   fms-related tyrosine kinase 1                     FLT1         910               379              -2.40             0.003257
  D78156                   RAS p21 protein activator 2                       RASA2        327               144              -2.26             0.002332
  U77783                   glutamate receptor                                GRIN2D       518               240              -2.15             0.001379
  D49394                   5-hydroxytryptamine receptor 3A                   HTR3A        197               98               -2.02             0.002493
                                                                                                                                               
                           **Nucleic Acid Binding**                                                                                            
  Z30425                   nuclear receptor subfamily 1, group I, member 3   NR1I3        1008              356              -2.83             0.000329
  U18760                   nuclear factor I/X                                NFIX         5796              2216             -2.62             0.000711
  AI223140                 purine-rich element binding protein A             PURA         1137              506              -2.25             0.002448
  AF015950                 telomerase reverse transcriptase                  TERT         561               255              -2.20             0.002839
  U40462                   zinc finger protein, subfamily 1A, 1              ZNFN1A1      662               308              -2.15             0.001171
  Z93930                   X-box binding protein 1                           XBP1         2223              1061             -2.09             0.000277
  AB019410                 PET112-like                                       PET112A      1422              707              -2.01             0.001309
                                                                                                                                               
                           **Ligand Binding**                                                                                                  
  X00129                   retinol binding protein 4, plasma                 RBP4         1517              68               -22.27            0.004809
  AJ223317                 sarcosine dehydrogenase                           SARDH        3844              1069             -3.60             0.000085
  AB017494                 LCAT-like lysophospholipase                       LYPLA3       906               326              -2.78             0.001131
  U78735                   ATP-binding cassette, sub-family A, member 3      ABCA3        1914              706              -2.71             0.000288
  AF026488                 spectrin, beta, non-erythrocytic 2                SPTBN2       1604              671              -2.39             0.00005
  U83659                   ATP-binding cassette, sub-family C, member 3      ABCC3        1287              551              -2.34             0.00244
  R93527                   metallothionein 1H                                MT1H         5093              2196             -2.32             0.002937
  AA586894                 S100 calcium binding protein A7                   S100A7       507               221              -2.29             0.000537
  U91329                   kinesin family member 1C                          KIF1C        2981              1484             -2.01             0.000518

###### 

Genes significantly decreased in tumors (continued).

  **GeneChip Accession**   **Gene Description**                                 **Symbol**   **Normal Mean**   **Tumor Mean**   **Fold Change**   **P value**
  ------------------------ ---------------------------------------------------- ------------ ----------------- ---------------- ----------------- -------------
                           **Enzyme**                                                                                                             
  M81057                   carboxypeptidase B1                                  CPB1         4534              79               -57.09            0.001106
  X71345                   protease, serine, 4                                  PRSS3        3859              76               -51.11            0.004102
  X01683                   serine (or cysteine) proteinase inhibitor, clade A   SERPINA1     2550              74               -34.64            0.004833
  M24400                   chymotrypsinogen B1                                  CTRB1        5158              207              -24.95            0.001744
  M18700                   elastase 3A, pancreatic                              ELA3A        7058              384              -18.37            0.000009
  U66061                   protease, serine, 1                                  PRSS1        7291              645              -11.31            0.000047
  L22524                   matrix metalloproteinase 7                           MMP7         595               54               -11.03            0.002591
  AI655458                 5-oxoprolinase (ATP-hydrolysing)                     OPLAH        446               99               -4.52             0.004072
  H94881                   FXYD domain-containing ion transport regulator 2     FXYD2        3116              708              -4.40             0.000539
  AL021026                 flavin containing monooxygenase 2                    FMO2         905               215              -4.21             0.000804
  AC005525                 plasminogen activator, urokinase receptor            PLAUR        1779              566              -3.14             0.000031
  U40370                   phosphodiesterase 1A, calmodulin-dependent           PDE1A        268               89               -3.03             0.004023
  R90942                   sialyltransferase 7D                                 SIAT7D       3148              1052             -2.99             0.002319
  M84472                   hydroxysteroid (17-beta) dehydrogenase 1             HSD17B1      1196              440              -2.72             0.000991
  X55988                   ribonuclease, RNase A family, 2                      RNASE2       480               203              -2.36             0.001314
  AB003151                 carbonyl reductase 1                                 CBR1         4538              1945             -2.33             0.000511
  X08020                   glutathione S-transferase M1                         GSTM1        2766              1376             -2.01             0.000519
                                                                                                                                                  
                           **Embryogenesis**                                                                                                      
  U15979                   delta-like homolog                                   SIGLEC5      3384              402              -8.41             0.002927
  M60094                   H1 histone family, member T                          HIST1H1T     976               230              -4.23             0.001639
  U50330                   bone morphogenetic protein 1                         BMP1         3298              973              -3.39             0.001637
  M74297                   homeo box A4                                         HOXA4        501               176              -2.85             0.000477
  AJ011785                 sine oculis homeobox homolog 6                       SIX6         530               190              -2.79             0.000286
  U66198                   fibroblast growth factor 13                          FGF13        191               73               -2.61             0.001068
  D31897                   double C2-like domains, alpha                        DOC2A        1151              451              -2.55             0.000068
  U12472                   glutathione S-transferase pi                         GSTP1        3122              1524             -2.05             0.000237
                                                                                                                                                  
                           **Transcription**                                                                                                      
  AL049228                 pleckstrin homology domain interacting protein       PHIP         257               33               -7.69             0.000782
  M27878                   zinc finger protein 84                               ZNF84        54                15               -3.64             0.001108
  U77629                   achaete-scute complex-like 2                         ASCL2        438               184              -2.38             0.000058
  D50495                   transcription elongation factor A, 2                 TCEA2        1330              595              -2.23             0.000019
  U49857                   transcriptional activator of the c-fos promoter      CROC4        542               259              -2.09             0.003894

###### 

Genes significantly decreased in tumors (continued).

  **GeneBank Accession**   **Gene Description**                                **Symbol**   **Normal Mean**   **Tumor Mean**   **Fold Change**   **P value**
  ------------------------ --------------------------------------------------- ------------ ----------------- ---------------- ----------------- -------------
                           **Other/Undefined**                                                                                                   
  X72475                   immunoglobulin kappa constant                       IGKC         1409              276              -5.11             0.000111
  D17570                   zona pellucida binding protein                      ZPBP         355               71               -5.02             0.001107
  M90657                   transmembrane 4 superfamily member 1                TM4SF1       592               141              -4.20             0.004537
  AF063308                 mitotic spindle coiled-coil related protein         SPAG5        2015              502              -4.01             0.000588
  U66059                   T cell receptor beta locus                          TRB@         3022              779              -3.88             0.000266
  AL022165                 carbohydrate sulfotransferase 7                     CHST7        359               94               -3.82             0.001738
  U10694                   melanoma antigen, family A, 9                       MAGEA9       1039              272              -3.82             0.000067
  M73255                   vascular cell adhesion molecule 1                   VCAM1        80                22               -3.66             0.004179
  U47926                   leprecan-like 2 protein                             LEPREL2      1003              319              -3.15             0.00013
  L05424                   CD44 antigen                                        CD44         1439              471              -3.05             0.001361
  AI445461                 transmembrane 4 superfamily member 1                TM4SF1       463               161              -2.88             0.002911
  AF010310                 proline oxidase homolog                             PRODH        1194              421              -2.84             0.000005
  AF000991                 testis-specific transcript, Y-linked 2              TTTY2        700               254              -2.76             0.000542
  X57522                   transporter 1, ATP-binding cassette, sub-family B   TAP1         781               287              -2.72             0.000971
  AA314825                 trefoil factor 1                                    TFF1         1657              616              -2.69             0.000011
  AB020880                 squamous cell carcinoma antigen                     SART3        3228              1224             -2.64             0.000135
  AF040707                 homologous to yeast nitrogen permease               NPR2L        1131              437              -2.59             0.001537
  U47292                   trefoil factor 2                                    TFF2         359               141              -2.54             0.000684
  X69398                   CD47 antigen                                        CD47         350               144              -2.42             0.000853
  U27331                   fucosyltransferase 6                                FUT6         1105              473              -2.34             0.000872
  AI827730                 cyclin M2                                           CNNM2        5863              2535             -2.31             0.000484
  U05255                   glycophorin B                                       GYPB         1606              717              -2.24             0.00013
  M34428                   pvt-1 oncogene homolog, MYC activator               PVT1         1231              550              -2.24             0.004423
  U86759                   netrin 2-like                                       NTN2L        2039              937              -2.18             0.000204
  D90278                   CEA-related cell adhesion molecule 3                CEACAM3      4388              2024             -2.17             0.000902
  L40400                   ZAP3 protein                                        ZAP3         1549              719              -2.15             0.000776
  U48224                   beaded filament structural protein 2, phakinin      BFSP2        568               271              -2.10             0.000166
  AI138834                 deltex homolog 2                                    DTX2         311               148              -2.10             0.000687
  M13755                   interferon-stimulated protein, 15 kDa               G1P2         1507              741              -2.03             0.001157
  X52228                   mucin 1, transmembrane                              MUC1         1523              756              -2.02             0.001707

Validation of GeneChip Data with Quantitative RT-PCR
----------------------------------------------------

In order to evaluate how accurately the GeneChip data was representing actual gene expression levels, eleven genes were tested with quantitative RT-PCR (Q-PCR). The results are shown in Table [9](#T9){ref-type="table"}. The correlation coefficients ranged from 0.964 to 0.235 with an average of 0.655. The lower correlation coefficients were associated with genes with larger numbers of exons. There was some association of low correlation with low average numerical expression values. The lowest correlations were associated with very faint image intensity of the involved genes in the dChip visual representation. The correlation coefficients of 4 genes, identified as apoptosis-related, was examined in detail (Figure [5](#F5){ref-type="fig"}). IER3, IAPP, SST, and PHLDA2 all had good correlation between GeneChip and Q-PCR results. FGF9, a potential growth stimulating gene was also examined (Figure [6](#F6){ref-type="fig"}). Again, there was overall good correlation between the individual GeneChip and Q-PCR results.

###### 

Correlation of GeneChip expression with quantitative RT-PCR.

  Gene Symbol   Correlation   Probe Set     Exons   Gene Size (bp)   Fold Change (T/N)   P value GeneChip T vs. N
  ------------- ------------- ------------- ------- ---------------- ------------------- --------------------------
  IER3          0.964         1237_at       1       1236             -4.6                0.0000
  SST           0.925         37782_at      2       351              -12                 0.0000
  PHLDA2        0.909         40237_at      2       913              -2.01               0.0003
  REG1B         0.875         35981_at      6       773              -499                0.0000
  IAPP          0.823         37871_at      3       1462             -4.68               0.0033
  REG1A         0.814         38646_s\_at   6       808              -16.9               0.0000
  FGF9          0.74          1616_at       3       1420             3.97                0.0031
  CBLB          0.327         514_at        21      3923             3.01                0.0009
  XPC           0.318         1873_at       16      3658             4.38                0.0018
  HRK           0.273         34011_at      2       716              -2.27               0.0011
  PTK2B         0.235         2009_at       38      4715             -2.94               0.0019
  Average       0.655                                                                    

![The expression levels of 4 apoptosis-related genes are shown by GeneChip and quantitative RT-PCR: a) IER3; b) IAPP; c) SST; d) PHLDA2. Normals (N) and tumors (T) are shown. Solid bars represent GeneChip and open bars represent Q-PCR results.](1476-4598-4-9-5){#F5}

![FGF9 expression levels in tumors (T) and normals (N) by GeneChip and quantitative RT-PCR. Solid bars represent GeneChip and open bars represent Q-PCR results.](1476-4598-4-9-6){#F6}

Discussion
==========

Whether there were degradative processes acting on the tissues prior to or during or after the extraction of the RNA can be guessed by the quality of the RNA. Each RNA specimen in this study was tested on an Affymetrix test chip, and each was found to be acceptable. Additional quality assessment was made by the dChip software. Only one specimen, a normal control, had Array Outliers greater than 5%, suggesting that it was subnormal (Table [2](#T2){ref-type="table"}). However, since the percent outliers was only 5.94, the chip was included in the analysis.

Although, only solid tumor was utilized, there were undoubtedly a small percentage of blood, blood vessel, and connective tissue elements intermixed with the tumor tissue. Rarely, there might be a small amount of exocrine tissue. In the case of the normal islets used as controls, microscopic examination showed that greater than 90% of the tissue was islet. Any contaminants would probably have the effect of reducing the discriminant power to differentiate tumor from normal. Thus, t-test p values and fold changes would tend to under-represented and some, otherwise significant, genes might be missed. The actual data, represented by the hierarchical specimen clustering (Figure [3](#F3){ref-type="fig"}), showed strong differential gene expression relating to group identity as would be expected if the overall gene expression levels were accurate. All the normals clustered together, separate from all the tumors. Within the normals, the two male specimens clustered in one group, and the two female in another. All the normal islet preparations, which are composed predominantly of beta cells, clustered closer to the insulinoma tumors than to the other neuroendocrine tumor types. The gene clustering results revealed 19 apoptosis-related genes whose expression was suppressed in the islet tumors relative to the normals. This suggests that apoptosis may play a significant role in the development of these tumors.

One might have expected more variation in the gene expression levels in the tumors than in the normal islets, since tumors are often heterogonous. However the data on the average CV of the genes in the normal and tumor groups suggested that there was no more variation in the tumors (average CV of 30%) than in the normals (average CV of 31%). The low CV in the tumors may relate to the single mode of tumor formation (induction by the loss of the menin tumor suppressor). However, there was increased variation noted when the tumors and normals were combined (Figure [2](#F2){ref-type="fig"}). This was probably the result of the differences in expression between the tumors and the normals.

Of particular interest was the high proportion (3/8) of tumors expressing principally PP hormonal RNA. This was entirely consistent with pathological studies showing the preponderance of PP containing tumors in the pancreas of MEN1 patients \[[@B31]\]. The fact that the clinical classification of two patients (9 and 11) was different than indicated by the hormone expression profile of the tumor analyzed was a consequence of the facts that those patients had multiple tumors secreting multiple hormones but only insulin and gastrin and sometime PP over secretion are likely to result in a clinical diagnosis.

The use of the Students t-test for comparison of multiple genes might be questioned because the test was designed for comparison of only two groups. In this study, we confirmed that comparison of 923 genes would not generate an excess number of false positive results. Nevertheless, in the group of 193 genes finally selected at a p \< = .005, we can expect that 1 of those genes is a false positive.

This study suggests that the overall effect of loss of function of menin is the suppression of gene expression. Nevertheless, there were 86 genes that were over-expressed in the tumors relative to the normals. Although we associate tumorigenesis with increased rates of growth, only two of eleven Cell Cycle and Cell Proliferation genes were increased in the tumors. Since tumor growth may also be significantly affected by rates of cell death, it is perhaps significant that there were no Cell Death genes significantly increased in the tumors relative to the controls.

The correlation of GeneChip results with quantitative real-time PCR (Q-PCR, Table [9](#T9){ref-type="table"}) was relatively good. However, there were some genes that correlated poorly (correlation coefficient less than 0.6). Interestingly, most of the genes with poor correlation coefficients had a large number of exons, whereas those with high correlation coefficients had a low number of exons. Since exhaustive testing of alternative primer pairs for Q-PCR was not made, it is possible that correlation coefficients of some genes could be improved by the use of other primers.

Four studies of global gene expression in pancreatic islets have been published recently \[[@B32]-[@B35]\]. Cardozo et al \[[@B32]\] have used microarrays to look for NF-kB dependent genes in primary cultures of rat pancreatic islets. Shalev et al \[[@B33]\] have measured global gene expression in purified human islets in tissue culture under high and low glucose concentrations. They noted that the TGFβ superfamily member PDF was down regulated 10-fold in the presence of glucose, whereas other TGFβ superfamily members were up regulated. In the current study, none of the TGFβ superfamily members were significantly different between tumor and normal. Scearce et al \[[@B34]\] have used a pancreas-specific micro-chip, the PanChip to analyze gene expression patterns in E14 to adult mice. Only a few specific genes were noted in the paper, and none of them had human homologs of significance to the current study. Maitra et al \[[@B35]\] conducted a study which in many ways was similar to the current one. They compared gene expression, using the Affymetrix U133A chip, in a series of sporadic pancreatic endocrine tumors with isolated normal islets. There was no overlap in the genes they identified (having a three-fold or greater difference in expression) with the genes we identified (having a two-fold or greater difference in expression). This is quite surprising, but perhaps suggests that sporadically arising tumors may have a quite different pattern of gene expression than tumors arising as a result of menin loss or dysfunction. Another possible cause of the differences may be the different Affymetrix GeneChips used in the two studies.

The question of which (if any) of the genes delineated in this study are a direct and necessary affect of loss-of-menin tumorigenesis cannot be determined by this study alone. Firstly, the activity of many genes are regulated both by their levels of expression and by post-translation modifications, such as phosphorylation. Secondly, the microchips used in this study represent only about 1/3 of the total number of human genes. Thirdly, it is not certain that the initiating gene changes caused by loss-of-menin are persistent in the tumors that develop. However, there were some genes, which because of their association with growth or apoptosis are of special interest. The general suppression of apoptosis related genes noted in this study (Figure [4](#F4){ref-type="fig"}) has been highlighted by the recent study of Schnepp *et al*, \[[@B36]\] who showed a loss of menin suppression of apoptosis in murine embryonic fibroblasts through a caspase-8 mechanism. Specific apoptosis-related genes which were suppressed in the tumors in the current study, and which were confirmed by Q-PCR include IER3, SST, PHLDA2, and IAPP. IER3 (IEX-1) is regulated by several transcription factors and may have positive or negative effects upon cell growth and apoptosis depending upon the cell-specific context \[[@B37]\]. Several studies have shown that it can be a promoter of apoptosis \[[@B38]-[@B40]\]. Somatostatin has shown a wide range of growth inhibitory activity *in vitro*and *in vivo*\[[@B41]-[@B57]\].PHLDA2 (TSSC3) is an imprinted gene homologous to the murineTDAG51 apoptosis-related gene \[[@B58]\], and may be involved in human brain tumors \[[@B59]\]. IAPP (amylin) is a gene which has contrasting activities and has been associated with experimental diabetes in rodents \[[@B60]\]. Amylin deposits were increased in islets of patients with gastrectomy-induced islet atrophy \[[@B61]\]. On the other hand, exposure of rat embryonic islets to amylin results in beta cell proliferation \[[@B62]\]. In contrast, amylin has been shown to induce apoptosis in rat and human insulinoma cells *in vitro*\[[@B63],[@B64]\]. In contrast to the suppression of apoptosis-related genes, FGF9 (Figure [6](#F6){ref-type="fig"}), a growth promoting gene, was significantly increased in the neuroendocrine tumors. This protein has been reported to play roles in glial cell growth \[[@B65]\], chondrocyte growth \[[@B66]\], prostate growth \[[@B67]\], endometrial growth \[[@B68]\], and has been suggested to have a role in human oncogenesis \[[@B69]\].

A recent report by Busygina et al \[[@B70]\] suggested that loss of menin can lead to hypermutability in a *Drosophila*model for MEN1. The spectrum of mutation sensitivity suggested that there was a defect in nucleotide excision repair. Whether the defect was a direct or indirect effect of menin loss was not stated. In the current study, there was a 2.44-fold decrease, in the tumors, in the expression of ERCC4 (Table [5](#T5){ref-type="table"}), a gene involved in nucleotide excision repair. In addition, XRCC4, a gene involved in double-strand break repair, was also decreased in the tumors in the current study.

Conclusion
==========

This first study of global gene expression in neuroendocrine tumors arising in the pancreas of patients with the MEN1 syndrome has identified many genes that are differentially expressed, as compared with normal human islet cells. A number of these genes are strongly over/under expressed and are attractive candidates for further investigation into the mechanisms by which menin loss causes tumors in pancreatic islets. Of particular interest was a group of 24 apoptosis-related genes that were significantly differentially expressed (mostly underexpressed) in the group of neuroendocrine tumors. The underexpression of these apoptosis-related genes may be related to neoplastic development or progression in these MEN1-related neuroendocrine tumors.

Methods
=======

Human Tissue Specimens
----------------------

Tumor specimens were obtained from patients with the MEN1 syndrome who had undergone surgery for islet-cell tumors of the pancreas. The specific germline mutations in the menin tumor suppressor gene were identified and previously reported \[[@B6]\] for each of the patients. Six of the patients had frame-shift mutations and one had a nonsense mutation. Informed consent was obtained in advance, and tumor tissues not needed for pathological analysis were snap frozen in liquid nitrogen, and kept frozen at -70° prior to RNA extraction. Normal pancreatic islets (which were originally intended for human transplatation studies, but were not used) were isolated from brain-dead donors by a collagenase procedure, as previously described \[[@B71]\], and were then frozen until used for extraction of RNA. Human Studies Committee approval from Washington University School of Medicine was obtained for this study.

Isolation of RNA from Tissue Specimens
--------------------------------------

Approximately 50 mg of tissue was removed from each frozen tumor specimen and homogenized with a mortar and pestle (Qiagen, Qiashredder Kit), and RNA was extracted using the Rneasy Mini Kit (Qiagen, Inc.), and quantified by UV absorbance. RNA was similarly isolated from the normal human islet preparations.

GeneChip Hybridization and Analysis
-----------------------------------

The RNA was submitted to the GeneChip facility of the Siteman Cancer Center at Washington University School of Medicine. There, biotin labeled cRNA was prepared and hybridized to U95Av2 microarray chips (Affymetrix). The fluorescence of individual spots was then measured and the data returned on compact discs. We analyzed the gene expression data and made comparisons between groups using the dChip computer program \[[@B30]\]. Following normalization (to equalize the overall intensity of each chip), the expression of each gene was determined by statistical modeling procedure in the dChip software. Each gene was represented by an array of 10 perfect match oligonucleotide spots and 10 mismatch oligonucleotide spots on the U95Av2 chip. The dChip program examines all the spots on all the chips involved in the study, and by a statistical procedure determines single and array outliers. These outliers can be considered as \"bad\" readings, and removed from further consideration.

Quantitative RT-PCR
-------------------

The same preparations of total RNA that were used to probe the GeneChips were also used to prepare c-DNA for quantitative RT-PCR analysis of gene expression. C-DNA was first prepared using Superscript II reverse transcriptase (Invitrogen, Inc.). Primers for each gene were designed to produce products of 100 to 150 bp that spanned exon boundaries (when possible). The primer pairs are shown in table [10](#T10){ref-type="table"}.

  **Gene**   **Forward Primer**            **Reverse Primer**
  ---------- ----------------------------- -----------------------------
  CBLB       cacgtctaaatctatagcagccagaac   tgcactcccaagcctcttctc
  FGF9       cggcaccagaaattcacaca          aaattgtctttgtcaactttggcttag
  HRK        agctggttcccgttttcca           cagtcccattctgtgtttctacgat
  IAPP       ctgctttgtatccatgagggttt       gaggtttgctgaaagccacttaa
  ER3        ccagcatctcaactccgtctgt        caccctaaaggcgacttcaaga
  SST        cccagactccgtcagtttctg         tacttggccagttcctgcttc
  PHLDA2     tgcccattgcaaataaatcact        ctgcccgcccattcct
  PTK2B      gtgaggagtgcaagaggcagat        gccagattggccagaacct
  REG1A      cctcaagcacaggattccaga         acatgtattttccagctgcctcta
  REG1B      gggtccctggtctcctacaagt        catttcttgaatcctgagcatgaa
  XPC        gcccgcaagctggacat             atcagtcacgggatgggagta

The Sybr Green technique on an Applied Biosystems model GeneAmp 5700 instrument was utilized. Relative quantitation using a standard c-DNA preparation from an *in vitro*islet tumor cell line was utilized.
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